

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 8.65649088 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 8.65649088 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 8.65649088 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 8.65649088 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 8.65649088 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 8.65649088 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.49491911 |
| 8 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.75118590 |
| 9 | response to host immune response (GO:0052572) | 5.75118590 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 5.66347564 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 5.46932060 |
| 12 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.34227696 |
| 13 | regulation of interferon-alpha production (GO:0032647) | 5.18234149 |
| 14 | response to peptidoglycan (GO:0032494) | 5.12283824 |
| 15 | response to host (GO:0075136) | 5.11926307 |
| 16 | response to host defenses (GO:0052200) | 5.11926307 |
| 17 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 5.11926307 |
| 18 | microglial cell activation (GO:0001774) | 4.94343771 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.86961843 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.84658901 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.47457684 |
| 22 | macrophage activation (GO:0042116) | 4.14012384 |
| 23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.12143603 |
| 24 | positive regulation of interferon-beta production (GO:0032728) | 4.01686788 |
| 25 | positive regulation of antigen processing and presentation (GO:0002579) | 3.98109723 |
| 26 | apoptotic cell clearance (GO:0043277) | 3.97015345 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.85571233 |
| 28 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.82478433 |
| 29 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.82090055 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.77623942 |
| 31 | regulation of mast cell degranulation (GO:0043304) | 3.77525385 |
| 32 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.75734399 |
| 33 | negative regulation of granulocyte differentiation (GO:0030853) | 3.74213161 |
| 34 | negative regulation of cell killing (GO:0031342) | 3.72921021 |
| 35 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.72921021 |
| 36 | respiratory burst (GO:0045730) | 3.71457747 |
| 37 | pinocytosis (GO:0006907) | 3.70128771 |
| 38 | regulation of antigen processing and presentation (GO:0002577) | 3.63017403 |
| 39 | negative regulation of mast cell activation (GO:0033004) | 3.61471581 |
| 40 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.61001845 |
| 41 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.60520223 |
| 42 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.59826163 |
| 43 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.58181394 |
| 44 | T-helper 1 type immune response (GO:0042088) | 3.57603268 |
| 45 | detection of other organism (GO:0098543) | 3.54783813 |
| 46 | regulation of cholesterol storage (GO:0010885) | 3.54047957 |
| 47 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.52302707 |
| 48 | positive regulation of type 2 immune response (GO:0002830) | 3.51026369 |
| 49 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.49787842 |
| 50 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.48348531 |
| 51 | regulation of mast cell activation (GO:0033003) | 3.47359659 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.46188947 |
| 53 | myeloid dendritic cell differentiation (GO:0043011) | 3.44091445 |
| 54 | B cell mediated immunity (GO:0019724) | 3.43610326 |
| 55 | I-kappaB phosphorylation (GO:0007252) | 3.38485008 |
| 56 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.38402727 |
| 57 | response to muramyl dipeptide (GO:0032495) | 3.37416867 |
| 58 | neutrophil activation (GO:0042119) | 3.36914491 |
| 59 | positive regulation of mast cell activation (GO:0033005) | 3.34847616 |
| 60 | granulocyte activation (GO:0036230) | 3.32574164 |
| 61 | detection of bacterium (GO:0016045) | 3.31625944 |
| 62 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.27927259 |
| 63 | glycosphingolipid catabolic process (GO:0046479) | 3.26981504 |
| 64 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.26766119 |
| 65 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.26471285 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 3.26386539 |
| 67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.24841559 |
| 68 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.24841559 |
| 69 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.23240439 |
| 70 | defense response to protozoan (GO:0042832) | 3.23158311 |
| 71 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.21540270 |
| 72 | positive regulation of cholesterol efflux (GO:0010875) | 3.21428146 |
| 73 | response to interferon-alpha (GO:0035455) | 3.19712404 |
| 74 | regulation of podosome assembly (GO:0071801) | 3.17335391 |
| 75 | amino sugar catabolic process (GO:0046348) | 3.17108844 |
| 76 | negative regulation of lipid storage (GO:0010888) | 3.15247684 |
| 77 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.15044492 |
| 78 | regulation of chronic inflammatory response (GO:0002676) | 3.14051287 |
| 79 | regulation of mononuclear cell migration (GO:0071675) | 3.13872056 |
| 80 | negative regulation of interleukin-12 production (GO:0032695) | 3.13328585 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 3.12821021 |
| 82 | type I interferon signaling pathway (GO:0060337) | 3.12431966 |
| 83 | cellular response to type I interferon (GO:0071357) | 3.12431966 |
| 84 | regulation of chemokine biosynthetic process (GO:0045073) | 3.11171633 |
| 85 | response to type I interferon (GO:0034340) | 3.10360071 |
| 86 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.09996779 |
| 87 | myeloid dendritic cell activation (GO:0001773) | 3.09684716 |
| 88 | regulation of interferon-beta production (GO:0032648) | 3.09326086 |
| 89 | response to protozoan (GO:0001562) | 3.08815894 |
| 90 | mannose metabolic process (GO:0006013) | 3.06211697 |
| 91 | regulation of gamma-delta T cell activation (GO:0046643) | 3.05786163 |
| 92 | neutrophil mediated immunity (GO:0002446) | 3.04770052 |
| 93 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.04591432 |
| 94 | positive regulation of heat generation (GO:0031652) | 3.03722728 |
| 95 | cellular response to interferon-gamma (GO:0071346) | 3.03698346 |
| 96 | positive regulation of mast cell degranulation (GO:0043306) | 3.03304728 |
| 97 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.03304728 |
| 98 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.03182774 |
| 99 | negative regulation of viral genome replication (GO:0045071) | 3.01313858 |
| 100 | regulation of type 2 immune response (GO:0002828) | 3.01309166 |
| 101 | regulation of interleukin-12 production (GO:0032655) | 3.00338530 |
| 102 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.98812325 |
| 103 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98491012 |
| 104 | regulation of leukocyte degranulation (GO:0043300) | 2.98073326 |
| 105 | regulation of vitamin metabolic process (GO:0030656) | 2.97268173 |
| 106 | germinal center formation (GO:0002467) | 2.96905658 |
| 107 | cellular response to interferon-alpha (GO:0035457) | 2.95815655 |
| 108 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95492109 |
| 109 | regulation of macrophage chemotaxis (GO:0010758) | 2.94400229 |
| 110 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.93657131 |
| 111 | superoxide anion generation (GO:0042554) | 2.92302208 |
| 112 | glycolipid catabolic process (GO:0019377) | 2.92056364 |
| 113 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91698970 |
| 114 | virion attachment to host cell (GO:0019062) | 2.91516973 |
| 115 | adhesion of symbiont to host cell (GO:0044650) | 2.91516973 |
| 116 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.90684928 |
| 117 | response to interferon-gamma (GO:0034341) | 2.90077822 |
| 118 | oligosaccharide catabolic process (GO:0009313) | 2.89826327 |
| 119 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.89422089 |
| 120 | negative regulation of phagocytosis (GO:0050765) | 2.88779781 |
| 121 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.88465575 |
| 122 | regulation of fever generation (GO:0031620) | 2.85895702 |
| 123 | detection of biotic stimulus (GO:0009595) | 2.85692559 |
| 124 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.85678673 |
| 125 | dendritic cell differentiation (GO:0097028) | 2.85053340 |
| 126 | cellular response to lipopolysaccharide (GO:0071222) | 2.83246393 |
| 127 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.82886876 |
| 128 | N-acetylneuraminate metabolic process (GO:0006054) | 2.82801732 |
| 129 | positive regulation of sterol transport (GO:0032373) | 2.80987050 |
| 130 | positive regulation of cholesterol transport (GO:0032376) | 2.80987050 |
| 131 | hyaluronan catabolic process (GO:0030214) | 2.79317021 |
| 132 | low-density lipoprotein particle clearance (GO:0034383) | 2.78685637 |
| 133 | positive regulation of B cell differentiation (GO:0045579) | 2.77517638 |
| 134 | detection of external biotic stimulus (GO:0098581) | 2.75213200 |
| 135 | negative regulation of interleukin-6 production (GO:0032715) | 2.73773560 |
| 136 | myeloid leukocyte activation (GO:0002274) | 2.71637886 |
| 137 | positive regulation of leukocyte degranulation (GO:0043302) | 2.70542951 |
| 138 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.67877600 |
| 139 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.66181641 |
| 140 | natural killer cell mediated immunity (GO:0002228) | 2.66181641 |
| 141 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.65816053 |
| 142 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.65554300 |
| 143 | cellular extravasation (GO:0045123) | 2.64599196 |
| 144 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.63951344 |
| 145 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.63365542 |
| 146 | response to lipoprotein particle (GO:0055094) | 2.62835753 |
| 147 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.62408443 |
| 148 | reactive oxygen species biosynthetic process (GO:1903409) | 2.61728053 |
| 149 | toxin transport (GO:1901998) | 2.60980272 |
| 150 | positive regulation of chemokine production (GO:0032722) | 2.59727378 |
| 151 | negative regulation of interleukin-17 production (GO:0032700) | 2.54911079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.64881940 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.24941067 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.33960968 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.45107527 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.21692955 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.70813271 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.59965554 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.45434033 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.38289221 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.07804574 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.95550052 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.61354938 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51652602 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.51110211 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.50742486 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.35703489 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.34931166 |
| 18 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.22377593 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.22004316 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06948072 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05488537 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.04280013 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.03793067 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88482586 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86707104 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.86566144 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85168509 |
| 28 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.78286315 |
| 29 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76715221 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76632569 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74758607 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71745540 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68262902 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.67878548 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67388894 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66930513 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66362613 |
| 38 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64014162 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62885716 |
| 40 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62223798 |
| 41 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.61822350 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58982961 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57769393 |
| 44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54396636 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50147693 |
| 46 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.49756875 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49176390 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.47051738 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44987003 |
| 50 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42126110 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42007523 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41191641 |
| 53 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37899199 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37438603 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36959980 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.36797939 |
| 57 | MYB_26560356_Chip-Seq_TH2_Human | 1.33789377 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31658893 |
| 59 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31086287 |
| 60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.30978331 |
| 61 | MYB_26560356_Chip-Seq_TH1_Human | 1.29850722 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29628390 |
| 63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28331205 |
| 64 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28309202 |
| 65 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28003188 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27253281 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25070122 |
| 68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21615310 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21128619 |
| 70 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20909129 |
| 71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20050572 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19181537 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18671523 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17214236 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15821910 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14253134 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13441656 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12366429 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09914373 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07565408 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02201645 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01892258 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99981719 |
| 84 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.97619425 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97358286 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96642076 |
| 87 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95988050 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95806293 |
| 89 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.94527184 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93406869 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93348216 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93197451 |
| 93 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92464287 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91866703 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91367248 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90104948 |
| 97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.88897136 |
| 98 | MAF_26560356_Chip-Seq_TH2_Human | 0.87827493 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87694150 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87498413 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85770328 |
| 102 | KDM2B_26808549_Chip-Seq_K562_Human | 0.85528820 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85417466 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84844486 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83984821 |
| 106 | MYC_22102868_ChIP-Seq_BL_Human | 0.83566898 |
| 107 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82287478 |
| 108 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81547323 |
| 109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80526190 |
| 110 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78263131 |
| 111 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.76988850 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75321513 |
| 113 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.74439180 |
| 114 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.70104368 |
| 115 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.68653942 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.67288934 |
| 117 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.67189508 |
| 118 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66154941 |
| 119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.64451157 |
| 120 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.60649942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.47039949 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.75813035 |
| 3 | MP0009840_abnormal_foam_cell | 3.29642771 |
| 4 | MP0003436_decreased_susceptibility_to | 3.27125935 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.16140834 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.07581860 |
| 7 | MP0004510_myositis | 3.04532922 |
| 8 | * MP0002419_abnormal_innate_immunity | 3.03400963 |
| 9 | MP0006082_CNS_inflammation | 2.64330082 |
| 10 | MP0003303_peritoneal_inflammation | 2.56331347 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.46943478 |
| 12 | * MP0005000_abnormal_immune_tolerance | 2.45336853 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.43647164 |
| 14 | MP0005025_abnormal_response_to | 2.41439556 |
| 15 | MP0003724_increased_susceptibility_to | 2.39060045 |
| 16 | MP0009785_altered_susceptibility_to | 2.38109388 |
| 17 | * MP0001790_abnormal_immune_system | 2.35839051 |
| 18 | * MP0005387_immune_system_phenotype | 2.35839051 |
| 19 | * MP0002452_abnormal_antigen_presenting | 2.30101496 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.18791654 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 2.11610062 |
| 22 | * MP0001800_abnormal_humoral_immune | 2.06489548 |
| 23 | * MP0002723_abnormal_immune_serum | 2.05289752 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.94717513 |
| 25 | MP0005451_abnormal_body_composition | 1.91300783 |
| 26 | * MP0001819_abnormal_immune_cell | 1.86522258 |
| 27 | * MP0002420_abnormal_adaptive_immunity | 1.85916552 |
| 28 | MP0003448_altered_tumor_morphology | 1.78906826 |
| 29 | MP0008469_abnormal_protein_level | 1.78009985 |
| 30 | MP0005671_abnormal_response_to | 1.75105198 |
| 31 | MP0008004_abnormal_stomach_pH | 1.73893219 |
| 32 | MP0000685_abnormal_immune_system | 1.72964393 |
| 33 | MP0008438_abnormal_cutaneous_collagen | 1.72449842 |
| 34 | MP0002405_respiratory_system_inflammati | 1.72190402 |
| 35 | MP0005670_abnormal_white_adipose | 1.71572779 |
| 36 | MP0001853_heart_inflammation | 1.68958119 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.66679286 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.65506448 |
| 39 | MP0009278_abnormal_bone_marrow | 1.62893746 |
| 40 | MP0000343_altered_response_to | 1.60802580 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.59847985 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.58112348 |
| 43 | MP0009764_decreased_sensitivity_to | 1.56916450 |
| 44 | MP0004947_skin_inflammation | 1.54722448 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.53313755 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.47032787 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.43655436 |
| 48 | MP0003690_abnormal_glial_cell | 1.42562465 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.40853529 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.39617021 |
| 51 | * MP0000689_abnormal_spleen_morphology | 1.36441362 |
| 52 | * MP0000716_abnormal_immune_system | 1.34040090 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.33003805 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.30007465 |
| 55 | MP0000604_amyloidosis | 1.28011457 |
| 56 | MP0006054_spinal_hemorrhage | 1.24914500 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.23251052 |
| 58 | MP0010307_abnormal_tumor_latency | 1.23211444 |
| 59 | MP0002398_abnormal_bone_marrow | 1.21631235 |
| 60 | MP0002933_joint_inflammation | 1.19728460 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.19274950 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.19274950 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.18988991 |
| 64 | MP0000858_altered_metastatic_potential | 1.17275686 |
| 65 | MP0003075_altered_response_to | 1.15953964 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.14109787 |
| 67 | MP0002722_abnormal_immune_system | 1.12505539 |
| 68 | * MP0002429_abnormal_blood_cell | 1.11933280 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.11817781 |
| 70 | MP0005390_skeleton_phenotype | 1.10128711 |
| 71 | MP0005310_abnormal_salivary_gland | 1.09001307 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.07192080 |
| 73 | MP0000371_diluted_coat_color | 1.06438842 |
| 74 | MP0003186_abnormal_redox_activity | 1.05170903 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.05068808 |
| 76 | MP0001851_eye_inflammation | 1.04118353 |
| 77 | MP0009763_increased_sensitivity_to | 1.03360039 |
| 78 | MP0001542_abnormal_bone_strength | 1.03322008 |
| 79 | MP0005164_abnormal_response_to | 1.02765542 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 1.00852299 |
| 81 | MP0010329_abnormal_lipoprotein_level | 0.96758329 |
| 82 | MP0002254_reproductive_system_inflammat | 0.96620209 |
| 83 | MP0004883_abnormal_blood_vessel | 0.94909766 |
| 84 | MP0000609_abnormal_liver_physiology | 0.93484277 |
| 85 | MP0000920_abnormal_myelination | 0.93059237 |
| 86 | MP0001873_stomach_inflammation | 0.92962968 |
| 87 | MP0003828_pulmonary_edema | 0.92125036 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.92105603 |
| 89 | MP0005083_abnormal_biliary_tract | 0.92024343 |
| 90 | MP0002166_altered_tumor_susceptibility | 0.86709611 |
| 91 | MP0005165_increased_susceptibility_to | 0.86351407 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.84999708 |
| 93 | MP0001663_abnormal_digestive_system | 0.82702815 |
| 94 | MP0003091_abnormal_cell_migration | 0.82520051 |
| 95 | MP0003705_abnormal_hypodermis_morpholog | 0.82388232 |
| 96 | MP0002132_abnormal_respiratory_system | 0.80704251 |
| 97 | MP0005166_decreased_susceptibility_to | 0.80621395 |
| 98 | MP0002006_tumorigenesis | 0.78398327 |
| 99 | MP0003011_delayed_dark_adaptation | 0.76902199 |
| 100 | MP0003879_abnormal_hair_cell | 0.76777703 |
| 101 | MP0001958_emphysema | 0.76350445 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.74476739 |
| 103 | MP0003795_abnormal_bone_structure | 0.74229101 |
| 104 | MP0003763_abnormal_thymus_physiology | 0.73792110 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.73274836 |
| 106 | MP0003329_amyloid_beta_deposits | 0.73212683 |
| 107 | MP0000598_abnormal_liver_morphology | 0.72280500 |
| 108 | MP0009115_abnormal_fat_cell | 0.71826190 |
| 109 | MP0000249_abnormal_blood_vessel | 0.71388999 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.71247481 |
| 111 | MP0008260_abnormal_autophagy | 0.71221790 |
| 112 | MP0003195_calcinosis | 0.70390206 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.70277559 |
| 114 | MP0008874_decreased_physiological_sensi | 0.68181134 |
| 115 | MP0010386_abnormal_urinary_bladder | 0.67539577 |
| 116 | MP0004019_abnormal_vitamin_homeostasis | 0.66867273 |
| 117 | MP0002090_abnormal_vision | 0.64814152 |
| 118 | MP0005334_abnormal_fat_pad | 0.64384910 |
| 119 | MP0000767_abnormal_smooth_muscle | 0.64126583 |
| 120 | MP0000490_abnormal_crypts_of | 0.63936245 |
| 121 | MP0005023_abnormal_wound_healing | 0.63677604 |
| 122 | MP0005365_abnormal_bile_salt | 0.63343376 |
| 123 | MP0005647_abnormal_sex_gland | 0.61575657 |
| 124 | MP0005535_abnormal_body_temperature | 0.60992208 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.59436573 |
| 126 | MP0003279_aneurysm | 0.55201783 |
| 127 | MP0004808_abnormal_hematopoietic_stem | 0.53653479 |
| 128 | MP0001501_abnormal_sleep_pattern | 0.53015786 |
| 129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51288803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.36319433 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.24258475 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 5.68421814 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 5.56523699 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.44682302 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.28530499 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.10999796 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.80318517 |
| 9 | Dysostosis multiplex (HP:0000943) | 4.58079369 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.56540888 |
| 11 | Glomerulonephritis (HP:0000099) | 4.47145049 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.33001515 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.33001515 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.33001515 |
| 15 | Mucopolysacchariduria (HP:0008155) | 3.89944518 |
| 16 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.89944518 |
| 17 | Mutism (HP:0002300) | 3.89106491 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.87860509 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.87860509 |
| 20 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.87860509 |
| 21 | Gingivitis (HP:0000230) | 3.69060408 |
| 22 | Joint hemorrhage (HP:0005261) | 3.68329832 |
| 23 | Complement deficiency (HP:0004431) | 3.66340935 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 3.45775437 |
| 25 | Abnormality of complement system (HP:0005339) | 3.40296310 |
| 26 | Myocardial infarction (HP:0001658) | 3.39951475 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.31318467 |
| 28 | Orchitis (HP:0100796) | 3.29438443 |
| 29 | Myositis (HP:0100614) | 3.28633229 |
| 30 | Recurrent skin infections (HP:0001581) | 3.24419558 |
| 31 | Nuclear cataract (HP:0100018) | 3.21061412 |
| 32 | Loss of speech (HP:0002371) | 3.16002470 |
| 33 | Periodontitis (HP:0000704) | 3.11567931 |
| 34 | Prostate neoplasm (HP:0100787) | 3.08301490 |
| 35 | Axonal loss (HP:0003447) | 2.97667702 |
| 36 | Keratoconjunctivitis (HP:0001096) | 2.93633777 |
| 37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.92879174 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.90306903 |
| 39 | Obstructive lung disease (HP:0006536) | 2.90306903 |
| 40 | Neurofibrillary tangles (HP:0002185) | 2.88531032 |
| 41 | Nephritis (HP:0000123) | 2.87140286 |
| 42 | Purpura (HP:0000979) | 2.86876836 |
| 43 | Disinhibition (HP:0000734) | 2.85664181 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.82436198 |
| 45 | Optic neuritis (HP:0100653) | 2.80150109 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.80150109 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.77547797 |
| 48 | Hepatosplenomegaly (HP:0001433) | 2.75581903 |
| 49 | Pathologic fracture (HP:0002756) | 2.73591569 |
| 50 | Hemoptysis (HP:0002105) | 2.68338672 |
| 51 | Increased serum ferritin (HP:0003281) | 2.68064009 |
| 52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.54620208 |
| 53 | Neuronal loss in central nervous system (HP:0002529) | 2.53594448 |
| 54 | Upper motor neuron abnormality (HP:0002127) | 2.51346109 |
| 55 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.49912932 |
| 56 | J-shaped sella turcica (HP:0002680) | 2.48976927 |
| 57 | Thick nail (HP:0001805) | 2.48498718 |
| 58 | IgM deficiency (HP:0002850) | 2.43579685 |
| 59 | Recurrent viral infections (HP:0004429) | 2.43405954 |
| 60 | Hematochezia (HP:0002573) | 2.43239164 |
| 61 | Inappropriate behavior (HP:0000719) | 2.43126742 |
| 62 | Apathy (HP:0000741) | 2.41594716 |
| 63 | Increased IgM level (HP:0003496) | 2.40858277 |
| 64 | Diminished motivation (HP:0000745) | 2.35732460 |
| 65 | Basal ganglia calcification (HP:0002135) | 2.35726524 |
| 66 | Asymmetric septal hypertrophy (HP:0001670) | 2.35712003 |
| 67 | Gingival bleeding (HP:0000225) | 2.34621196 |
| 68 | Pustule (HP:0200039) | 2.33616845 |
| 69 | Gangrene (HP:0100758) | 2.29370189 |
| 70 | Malnutrition (HP:0004395) | 2.29135679 |
| 71 | Agnosia (HP:0010524) | 2.27923095 |
| 72 | Encephalitis (HP:0002383) | 2.27770837 |
| 73 | Polyneuropathy (HP:0001271) | 2.26005397 |
| 74 | Osteolytic defects of the hand bones (HP:0009699) | 2.23879611 |
| 75 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23879611 |
| 76 | Petechiae (HP:0000967) | 2.23697405 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.23697266 |
| 78 | Vasculitis (HP:0002633) | 2.22330021 |
| 79 | Stomatitis (HP:0010280) | 2.21914744 |
| 80 | Urticaria (HP:0001025) | 2.18490720 |
| 81 | Epistaxis (HP:0000421) | 2.17258446 |
| 82 | Pulmonary embolism (HP:0002204) | 2.16658326 |
| 83 | Osteomyelitis (HP:0002754) | 2.16441857 |
| 84 | Thoracic kyphosis (HP:0002942) | 2.14965716 |
| 85 | Gastrointestinal infarctions (HP:0005244) | 2.14760084 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 2.14289529 |
| 87 | Recurrent pneumonia (HP:0006532) | 2.14069784 |
| 88 | Interstitial pulmonary disease (HP:0006530) | 2.13028071 |
| 89 | Prolonged bleeding time (HP:0003010) | 2.11097455 |
| 90 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.10804665 |
| 91 | Bone pain (HP:0002653) | 2.10737250 |
| 92 | Menorrhagia (HP:0000132) | 2.09317008 |
| 93 | Increased IgE level (HP:0003212) | 2.08792265 |
| 94 | Personality changes (HP:0000751) | 2.08667908 |
| 95 | Cellulitis (HP:0100658) | 2.07280849 |
| 96 | Progressive visual loss (HP:0000529) | 2.06856691 |
| 97 | Leukocytosis (HP:0001974) | 2.06323765 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 2.05614800 |
| 99 | Memory impairment (HP:0002354) | 2.04225085 |
| 100 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04216980 |
| 101 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04216980 |
| 102 | Cerebral inclusion bodies (HP:0100314) | 2.04186097 |
| 103 | Nausea (HP:0002018) | 2.03386029 |
| 104 | T lymphocytopenia (HP:0005403) | 2.03002744 |
| 105 | Chronic otitis media (HP:0000389) | 1.99915762 |
| 106 | Vertigo (HP:0002321) | 1.97161238 |
| 107 | Pulmonary infiltrates (HP:0002113) | 1.97064466 |
| 108 | Abnormality of the pleura (HP:0002103) | 1.96925503 |
| 109 | Dementia (HP:0000726) | 1.94063338 |
| 110 | Abnormality of the nasal mucosa (HP:0000433) | 1.93170674 |
| 111 | Acne (HP:0001061) | 1.92916810 |
| 112 | Vertebral compression fractures (HP:0002953) | 1.92080398 |
| 113 | Deformed sella turcica (HP:0002681) | 1.90493505 |
| 114 | Metaphyseal irregularity (HP:0003025) | 1.90184285 |
| 115 | Amyloidosis (HP:0011034) | 1.88689893 |
| 116 | Abnormality of T cell number (HP:0011839) | 1.88183920 |
| 117 | Peripheral demyelination (HP:0011096) | 1.86750123 |
| 118 | Progressive neurologic deterioration (HP:0002344) | 1.86164297 |
| 119 | Retinal atrophy (HP:0001105) | 1.85635042 |
| 120 | Poor head control (HP:0002421) | 1.85143350 |
| 121 | Abnormality of the pericardium (HP:0001697) | 1.84174612 |
| 122 | Meningitis (HP:0001287) | 1.83994770 |
| 123 | Abnormality of the prostate (HP:0008775) | 1.82663575 |
| 124 | Tetraparesis (HP:0002273) | 1.82591552 |
| 125 | Recurrent lower respiratory tract infections (HP:0002783) | 1.81806607 |
| 126 | Albinism (HP:0001022) | 1.81554369 |
| 127 | Keratoconjunctivitis sicca (HP:0001097) | 1.79599418 |
| 128 | Hypercholesterolemia (HP:0003124) | 1.79408063 |
| 129 | Arterial thrombosis (HP:0004420) | 1.78574270 |
| 130 | Abnormality of the lumbar spine (HP:0100712) | 1.76439585 |
| 131 | Inflammation of the large intestine (HP:0002037) | 1.75618758 |
| 132 | Colitis (HP:0002583) | 1.74555389 |
| 133 | Absent frontal sinuses (HP:0002688) | 1.73497462 |
| 134 | Anorexia (HP:0002039) | 1.72892091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.81971243 |
| 2 | MAP4K1 | 4.04003637 |
| 3 | IRAK4 | 3.81476885 |
| 4 | TYK2 | 3.43456677 |
| 5 | BLK | 3.01667440 |
| 6 | KIT | 2.97300507 |
| 7 | ERN1 | 2.80626163 |
| 8 | MAP3K14 | 2.75699656 |
| 9 | TBK1 | 2.75016547 |
| 10 | TGFBR2 | 2.60635219 |
| 11 | IKBKE | 2.33250427 |
| 12 | DDR2 | 2.10721934 |
| 13 | CAMK1D | 2.04450178 |
| 14 | RIPK4 | 1.96903173 |
| 15 | TAOK1 | 1.91241289 |
| 16 | TXK | 1.80258863 |
| 17 | JAK1 | 1.80207484 |
| 18 | JAK3 | 1.72602523 |
| 19 | IKBKB | 1.71655203 |
| 20 | TAOK3 | 1.71173134 |
| 21 | ZAK | 1.62851026 |
| 22 | CSF1R | 1.57921294 |
| 23 | CDC42BPA | 1.54479939 |
| 24 | CSK | 1.49843872 |
| 25 | MAP2K3 | 1.46928798 |
| 26 | ZAP70 | 1.45306553 |
| 27 | HCK | 1.29912604 |
| 28 | NEK9 | 1.28963341 |
| 29 | MAP3K3 | 1.27941584 |
| 30 | ABL2 | 1.25875801 |
| 31 | PLK4 | 1.20340425 |
| 32 | STK10 | 1.13750594 |
| 33 | SYK | 1.13401221 |
| 34 | IRAK1 | 1.12958008 |
| 35 | FES | 1.12551744 |
| 36 | CAMK1G | 1.11059944 |
| 37 | TTN | 1.08425696 |
| 38 | MAP3K1 | 1.07212577 |
| 39 | TNK2 | 1.05822749 |
| 40 | FGR | 1.05497416 |
| 41 | ADRBK2 | 1.04454263 |
| 42 | BTK | 1.03336587 |
| 43 | CHUK | 1.03334669 |
| 44 | LYN | 1.01599717 |
| 45 | TEC | 0.96976136 |
| 46 | RPS6KA4 | 0.96764845 |
| 47 | IRAK2 | 0.94951398 |
| 48 | PIM1 | 0.93482701 |
| 49 | EIF2AK2 | 0.93477318 |
| 50 | JAK2 | 0.93165146 |
| 51 | RPS6KA6 | 0.91549627 |
| 52 | GRK7 | 0.91213070 |
| 53 | CLK1 | 0.89342040 |
| 54 | CDK12 | 0.88887652 |
| 55 | FGFR4 | 0.88370837 |
| 56 | MARK3 | 0.86415921 |
| 57 | ACVR1B | 0.86262633 |
| 58 | LCK | 0.86134335 |
| 59 | PIM2 | 0.85890801 |
| 60 | RPS6KC1 | 0.83844072 |
| 61 | RPS6KL1 | 0.83844072 |
| 62 | EPHB1 | 0.78405445 |
| 63 | CAMKK2 | 0.78256862 |
| 64 | EPHA3 | 0.73099760 |
| 65 | MATK | 0.72826821 |
| 66 | YES1 | 0.69184963 |
| 67 | TAOK2 | 0.69036601 |
| 68 | CDK6 | 0.68618478 |
| 69 | NME2 | 0.65031717 |
| 70 | MAP2K6 | 0.63936159 |
| 71 | TESK2 | 0.62971715 |
| 72 | KDR | 0.61364294 |
| 73 | TRPM7 | 0.61203302 |
| 74 | BMPR2 | 0.60823064 |
| 75 | PAK4 | 0.60274656 |
| 76 | ABL1 | 0.60100444 |
| 77 | PRKCD | 0.59634312 |
| 78 | MAPK7 | 0.57704694 |
| 79 | FGFR3 | 0.57289771 |
| 80 | INSRR | 0.56745382 |
| 81 | MARK2 | 0.56727972 |
| 82 | PDPK1 | 0.56331181 |
| 83 | HIPK2 | 0.55234128 |
| 84 | MAP3K11 | 0.55015593 |
| 85 | DAPK2 | 0.55010680 |
| 86 | TYRO3 | 0.54313518 |
| 87 | MAP3K13 | 0.53568208 |
| 88 | SGK3 | 0.53249721 |
| 89 | MAPK4 | 0.52365773 |
| 90 | TESK1 | 0.51337632 |
| 91 | EGFR | 0.51283411 |
| 92 | PDK1 | 0.50767361 |
| 93 | BRD4 | 0.50374091 |
| 94 | SIK3 | 0.50226198 |
| 95 | SIK1 | 0.47577455 |
| 96 | MAP3K6 | 0.46693750 |
| 97 | PTK6 | 0.45914318 |
| 98 | TRIB3 | 0.44722270 |
| 99 | MAP3K5 | 0.44261337 |
| 100 | PRPF4B | 0.37802621 |
| 101 | MOS | 0.37748453 |
| 102 | STK4 | 0.35547631 |
| 103 | FYN | 0.35253940 |
| 104 | PRKD2 | 0.35028320 |
| 105 | ICK | 0.33339188 |
| 106 | RIPK1 | 0.31983263 |
| 107 | PDGFRA | 0.31866246 |
| 108 | STK24 | 0.31822062 |
| 109 | SGK2 | 0.31663593 |
| 110 | ITK | 0.30650920 |
| 111 | BMX | 0.30362382 |
| 112 | GRK1 | 0.30337816 |
| 113 | ARAF | 0.30214549 |
| 114 | MAP2K2 | 0.29532204 |
| 115 | SIK2 | 0.29402667 |
| 116 | RPS6KA2 | 0.28789163 |
| 117 | PRKCH | 0.28617172 |
| 118 | DYRK3 | 0.28016141 |
| 119 | GRK6 | 0.27655717 |
| 120 | PKN1 | 0.27465356 |
| 121 | MAPK12 | 0.27423354 |
| 122 | BMPR1B | 0.27372718 |
| 123 | MAPKAPK2 | 0.26702205 |
| 124 | ATR | 0.26606305 |
| 125 | IGF1R | 0.26485504 |
| 126 | DYRK1B | 0.25762216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.66045533 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.96023089 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.35646911 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.34044762 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.95916817 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.52544813 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32271478 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.31751088 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.20332260 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19405508 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.18269155 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.18211671 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.08704319 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94795803 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 1.92594936 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.90434935 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.87388996 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76405619 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76049641 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.68626982 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66190703 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65394231 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56788446 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.49938349 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48892512 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41387813 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.33643191 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32012888 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30849122 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29819688 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29652235 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.26286502 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22264302 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21845234 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14308960 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11885125 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.11670954 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.10953442 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05691394 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.04334827 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.01978450 |
| 42 | Asthma_Homo sapiens_hsa05310 | 0.96198422 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95682934 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93613206 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93387227 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92817202 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87973945 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.87786934 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.86500755 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84439939 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 0.83565050 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83485331 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79481455 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77964801 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76130230 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75253923 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68341857 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66913951 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 0.65777847 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64513493 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.63451790 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63331917 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61863197 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61676821 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59355225 |
| 66 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54981460 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53925002 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53229407 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53131025 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52804793 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52774659 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50869079 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50275931 |
| 74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49712959 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.49644361 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49444178 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48886662 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48700463 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46555091 |
| 80 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46318346 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46029052 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45982994 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45894941 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45324157 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44683014 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.43373842 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.40730911 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39255653 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39083093 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.38403204 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.37457041 |
| 92 | Base excision repair_Homo sapiens_hsa03410 | 0.37154264 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34068532 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33356623 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.33036831 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32953693 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32176406 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.32170980 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31918916 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27694125 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.27345171 |
| 102 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.26384862 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25546109 |
| 104 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.25392168 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22183352 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21347660 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.21221334 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20954811 |
| 109 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.20593602 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20457252 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20435860 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.20311623 |
| 113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.20279791 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19690519 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19574019 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.19466086 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16850456 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.16575725 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16333613 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.14905985 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13463185 |

